Skip to content

Effectiveness of homoeopathic medicine in reducing Anti TPO levels in Hashimoto Thyroiditis.

ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES WITH LM POTENCY IN REDUCING ANTI TPO LEVELS OF HASHIMOTOS THYROIDITIS A SINGLE ARM CLINICAL STUDY - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089087
Enrollment
38
Registered
2025-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E063- Autoimmune thyroiditis

Interventions

Intervention1: INDIVIDUALISED HOMOEOPATHY MEDICINE: After enrollment the case will be repertorised. Appropriate potentized Individualised Homoeopathic Medicine will be administered in minimum dose in

Sponsors

DIVYA M A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with Anti TPO above 34 IU/mL Participant from 18-60 years of age.

Exclusion criteria

Exclusion criteria: Cases with Malignant thyroid tumors. Patient with USG THYROID Findings TIRADS 4 or above Patients with other systemic illness like uncontrolled diabetes, Malignant Hypertension, Severe cardiac diseases, Malignancies. Immuno-compromised patients- HIV/AIDS, TB. Pregnant women and Lactating mothers.

Design outcomes

Primary

MeasureTime frame
Reduction in levels of Serum Anti TPO once in 3 monthsTimepoint: Baseline at 3rd 6th 9th month and at the conclusion of the study 12th month

Secondary

MeasureTime frame
To find out the effectiveness of individualized homoeopathic medicine with LM Potency in reducing of Serum TSH levels in Hashimoto thyroiditis To identify the psychological stress contributing to Hashimotos Thyroiditis through life space investigation during case takingTimepoint: Baseline at 3rd,6th,9th month and at the conclusion of the study 12th month

Countries

India

Contacts

Public ContactDIVYA M A

NHRIMH

krishneswarirs@gmail.com8903255833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026